• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物群:炎症性肠病的新型生物标志物来源?

Intestinal microbiota: a source of novel biomarkers in inflammatory bowel diseases?

机构信息

Department of Microbial Ecology, Faculty of Life Science, University of Vienna, Althanstr. 14, A-1090 Wien, Austria.

出版信息

Best Pract Res Clin Gastroenterol. 2013 Feb;27(1):47-58. doi: 10.1016/j.bpg.2013.03.005.

DOI:10.1016/j.bpg.2013.03.005
PMID:23768552
Abstract

The human intestine harbours a complex microbial ecosystem that performs manifold functions important to the nutrition and health of its host. Extensive study has revealed that the composition of the intestinal microbiota is altered in individuals with inflammatory bowel disease (IBD). The IBD associated intestinal microbiota generally has reduced species richness and diversity, lower temporal stability, and disruption of the secreted mucus layer structure. Multiple studies have identified certain bacterial taxa that are enriched or depleted in IBD including Enterobacteriaceae, Ruminococcus gnavus, and Desulfovibrio (enriched) and Faecalibacterium prausnitzii, Lachnospiraceae, and Akkermansia (depleted). Additionally, the relative abundance of some taxa appears to correlate with established markers of disease activity such as Enterobacteriaceae (enriched) and Lachnospiraceae (depleted). Signature shifts in fecal microbial community composition may therefore prove to be valuable as diagnostic biomarkers, particularly for longitudinal monitoring of disease activity and response to treatments.

摘要

人类肠道中栖息着一个复杂的微生物生态系统,这个系统对宿主的营养和健康具有多种重要功能。大量研究表明,患有炎症性肠病(IBD)的个体的肠道微生物群组成发生了改变。IBD 相关的肠道微生物群通常具有较低的物种丰富度和多样性、较低的时间稳定性,以及分泌的黏液层结构被破坏。多项研究已经确定了在 IBD 中富集或缺失的某些细菌分类群,包括肠杆菌科、瘤胃球菌属和脱硫弧菌(富集)以及普拉梭菌属、毛螺菌科和阿克曼氏菌(缺失)。此外,某些分类群的相对丰度似乎与疾病活动的既定标志物相关,如肠杆菌科(富集)和毛螺菌科(缺失)。因此,粪便微生物群落组成的特征性变化可能被证明是有价值的诊断生物标志物,特别是用于疾病活动的纵向监测和对治疗的反应。

相似文献

1
Intestinal microbiota: a source of novel biomarkers in inflammatory bowel diseases?肠道微生物群:炎症性肠病的新型生物标志物来源?
Best Pract Res Clin Gastroenterol. 2013 Feb;27(1):47-58. doi: 10.1016/j.bpg.2013.03.005.
2
Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.炎症性肠病患儿与健康同胞的肠道微生物群在分类和功能组成上存在差异:一项宏基因组分析。
Am J Physiol Gastrointest Liver Physiol. 2017 Apr 1;312(4):G327-G339. doi: 10.1152/ajpgi.00293.2016. Epub 2016 Dec 30.
3
The microbiota in inflammatory bowel disease in different age groups.不同年龄组炎症性肠病中的微生物群。
Dig Dis. 2009;27(3):252-8. doi: 10.1159/000228558. Epub 2009 Sep 24.
4
Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.炎症性肠病和结直肠癌中的微生物群变化:结肠细胞反应的改变
World J Gastroenterol. 2014 Dec 28;20(48):18121-30. doi: 10.3748/wjg.v20.i48.18121.
5
Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease.患有银屑病关节炎的患者肠道微生物多样性减少,其肠道微生物组与炎症性肠病中的失调类似。
Arthritis Rheumatol. 2015 Jan;67(1):128-39. doi: 10.1002/art.38892.
6
Does our food (environment) change our gut microbiome ('in-vironment'): a potential role for inflammatory bowel disease?我们的食物(环境)是否改变了肠道微生物组(“in-vironment”):炎症性肠病的潜在作用?
Dig Dis. 2012;30 Suppl 3:33-9. doi: 10.1159/000342595. Epub 2013 Jan 3.
7
Host responses to the human microbiome.人体微生物组的宿主反应。
Nutr Rev. 2012 Aug;70 Suppl 1:S14-7. doi: 10.1111/j.1753-4887.2012.00496.x.
8
The fecal microbiome in dogs with acute diarrhea and idiopathic inflammatory bowel disease.犬急性腹泻和特发性炎症性肠病的粪便微生物组。
PLoS One. 2012;7(12):e51907. doi: 10.1371/journal.pone.0051907. Epub 2012 Dec 26.
9
A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients.富含炎症性肠病患者的新型格尔曼梭菌分支。
Genome Med. 2017 Nov 28;9(1):103. doi: 10.1186/s13073-017-0490-5.
10
Debugging the intestinal microbiota in IBD.调试炎症性肠病中的肠道微生物群。
Gastroenterol Clin Biol. 2009 Jun;33 Suppl 3:S131-6. doi: 10.1016/S0399-8320(09)73148-3.

引用本文的文献

1
alleviates alcohol-associated liver disease by enhancing N-acetyl-glutamic acid levels and inhibiting ferroptosis through the KEAP1-NRF2 pathway.通过提高N-乙酰谷氨酸水平并通过KEAP1-NRF2途径抑制铁死亡来减轻酒精相关性肝病。
Gut Microbes. 2025 Dec;17(1):2517821. doi: 10.1080/19490976.2025.2517821. Epub 2025 Jun 13.
2
Balance between bile acid conjugation and hydrolysis activity can alter outcomes of gut inflammation.胆汁酸结合与水解活性之间的平衡会改变肠道炎症的结果。
Nat Commun. 2025 Apr 11;16(1):3434. doi: 10.1038/s41467-025-58649-x.
3
Gut dysbiosis was inevitable, but tolerance was not: temporal responses of the murine microbiota that maintain its capacity for butyrate production correlate with sustained antinociception to chronic morphine.
肠道菌群失调是不可避免的,但耐受性并非如此:维持丁酸盐产生能力的小鼠微生物群的时间反应与对慢性吗啡的持续抗伤害感受相关。
Gut Microbes. 2025 Dec;17(1):2446423. doi: 10.1080/19490976.2024.2446423. Epub 2025 Jan 12.
4
Gut dysbiosis was inevitable, but tolerance was not: temporal responses of the murine microbiota that maintain its capacity for butyrate production correlate with sustained antinociception to chronic morphine.肠道微生物群失调不可避免,但耐受性并非如此:维持其丁酸盐产生能力的小鼠微生物群的时间反应与对慢性吗啡的持续抗伤害感受相关。
bioRxiv. 2024 Nov 27:2024.04.15.589671. doi: 10.1101/2024.04.15.589671.
5
Therapeutic effects and mechanisms of isoxanthohumol on DSS-induced colitis: regulating T cell development, restoring gut microbiota, and improving metabolic disorders.异黄腐醇对 DSS 诱导的结肠炎的治疗作用及机制:调节 T 细胞发育、恢复肠道微生物群和改善代谢紊乱。
Inflammopharmacology. 2024 Jun;32(3):1983-1998. doi: 10.1007/s10787-024-01472-5. Epub 2024 Apr 20.
6
An Update on the Role and Potential Molecules in Relation to in Inflammatory Bowel Disease, Obesity and Diabetes Mellitus.炎症性肠病、肥胖症和糖尿病中相关作用及潜在分子的最新进展
Diabetes Metab Syndr Obes. 2024 Mar 11;17:1235-1248. doi: 10.2147/DMSO.S456173. eCollection 2024.
7
Classical and Innovative Evidence for Therapeutic Strategies in Retinal Dysfunctions.经典与创新证据在视网膜功能障碍治疗策略中的应用
Int J Mol Sci. 2024 Feb 9;25(4):2124. doi: 10.3390/ijms25042124.
8
Modified Gexia-Zhuyu Tang inhibits gastric cancer progression by restoring gut microbiota and regulating pyroptosis.加味膈下逐瘀汤通过恢复肠道微生物群和调节细胞焦亡来抑制胃癌进展。
Cancer Cell Int. 2024 Jan 9;24(1):21. doi: 10.1186/s12935-024-03215-6.
9
Twnbiome: a public database of the healthy Taiwanese gut microbiome.Twnbiome:一个公开的台湾健康肠道微生物组数据库。
BMC Bioinformatics. 2023 Dec 14;24(1):474. doi: 10.1186/s12859-023-05585-6.
10
From-Toilet-to-Freezer: A Review on Requirements for an Automatic Protocol to Collect and Store Human Fecal Samples for Research Purposes.从马桶到冰箱:关于用于研究目的的人类粪便样本采集与存储自动方案要求的综述
Biomedicines. 2023 Sep 28;11(10):2658. doi: 10.3390/biomedicines11102658.